D.E. Shaw & Co’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214K Sell
64,676
-114,359
-64% -$379K ﹤0.01% 2818
2025
Q1
$519K Buy
179,035
+52,571
+42% +$152K ﹤0.01% 2445
2024
Q4
$450K Buy
126,464
+95,418
+307% +$340K ﹤0.01% 2446
2024
Q3
$155K Buy
31,046
+20,858
+205% +$104K ﹤0.01% 2853
2024
Q2
$26.5K Sell
10,188
-85,025
-89% -$221K ﹤0.01% 2978
2024
Q1
$406K Buy
+95,213
New +$406K ﹤0.01% 2491
2022
Q3
Sell
-164,607
Closed -$106K 3879
2022
Q2
$106K Buy
164,607
+55,769
+51% +$35.9K ﹤0.01% 3541
2022
Q1
$284K Buy
108,838
+21,052
+24% +$54.9K ﹤0.01% 3469
2021
Q4
$341K Buy
+87,786
New +$341K ﹤0.01% 3264
2020
Q3
Sell
-283,418
Closed -$1.38M 2564
2020
Q2
$1.38M Buy
283,418
+69,196
+32% +$336K ﹤0.01% 1781
2020
Q1
$469K Sell
214,222
-49,195
-19% -$108K ﹤0.01% 2170
2019
Q4
$1.53M Buy
+263,417
New +$1.53M ﹤0.01% 1731